TYR and melanoma: Compared to α-MSH or [Nle4]-α-MSH, [Nle4-D-Phe7]-α-MSH was more resistant to enzymatic degradation by serum enzymes, and it exhibited significantly increased biological activity, as determined by activation of AC and stimulation of TYR activity in mouse melanoma cells [60].